Literature DB >> 18162223

Immune reconstitution in children after unrelated cord blood transplantation.

Paul Szabolcs1, Donna Niedzwiecki.   

Abstract

There is a great need to learn more about the biology of immune recovery after UCBT. Fundamental gaps in knowledge remain regarding the biology and kinetics of developing antigen-specific protective immunity and understanding the impact of recipient age and immunosuppressive agents. However, there is also realistic hope that clinical translation of new immunotherapy strategies could enhance immune competence after UCBT either by having an impact on the thymic-independent early period or by fostering thymic recovery.

Entities:  

Mesh：

Year:  2008        PMID： 18162223     DOI： 10.1016/j.bbmt.2007.10.016

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


  9 in total

Review 1.  Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Authors:  Young-June Kim; Hal E Broxmeyer
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-19       Impact factor: 6.312

2.  Modelling of neutrophil dynamics in children receiving busulfan or treosulfan for haematopoietic stem cell transplant conditioning.

Authors:  Belén P Solans; Robert Chiesa; Bilyana Doncheva; Helen Prunty; Paul Veys; Iñaki F Trocóniz; Joseph F Standing
Journal:  Br J Clin Pharmacol       Date:  2020-03-03       Impact factor: 4.335

3.  Role of defective thymic function in onset of ganciclovir-resistant cytomegalovirus after cord blood transplantation.

Authors:  Sara Cantisán; Carmen Martín; María C Romero-Sánchez; Sara Ferrando-Martínez; Francisco Martínez; Antonio Rivero; Antonio Torres; Rafael Solana; Julián Torre-Cisneros
Journal:  Clin Vaccine Immunol       Date:  2012-10-10

4.  Cord blood transplantation is associated with rapid B-cell neogenesis compared with BM transplantation.

Authors:  K Nakatani; K Imai; M Shigeno; H Sato; M Tezuka; T Okawa; N Mitsuiki; T Isoda; D Tomizawa; M Takagi; M Nagasawa; M Kajiwara; M Yamamoto; A Arai; O Miura; C Kamae; N Nakagawa; K Honma; S Nonoyama; S Mizutani; T Morio
Journal:  Bone Marrow Transplant       Date:  2014-06-30       Impact factor: 5.483

5.  Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation.

Authors:  Kenneth P Micklethwaite; Barbara Savoldo; Patrick J Hanley; Ann M Leen; Gail J Demmler-Harrison; Laurence J N Cooper; Hao Liu; Adrian P Gee; Elizabeth J Shpall; Cliona M Rooney; Helen E Heslop; Malcolm K Brenner; Catherine M Bollard; Gianpietro Dotti
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

6.  Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy.

Authors:  Moniek A de Witte; Dhifaf Sarhan; Zachary Davis; Martin Felices; Daniel A Vallera; Peter Hinderlie; Julie Curtsinger; Sarah Cooley; John Wagner; Jurgen Kuball; Jeffrey S Miller
Journal:  Biol Blood Marrow Transplant       Date:  2018-03-02       Impact factor: 5.742

7.  Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation.

Authors:  T W H Flinsenberg; L Spel; M Jansen; D Koning; C de Haar; M Plantinga; R Scholman; M M van Loenen; S Nierkens; L Boon; D van Baarle; M H M Heemskerk; J J Boelens; M Boes
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

Review 8.  The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression.

Authors:  Krishna V Komanduri; Eric D Wieder; Cara L Benjamin; Robert B Levy
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

9.  In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells.

Authors:  Yildian Díaz-Rodríguez; Paulo Cordeiro; Assila Belounis; Sabine Herblot; Michel Duval
Journal:  Cancer Immunol Immunother       Date:  2017-05-29       Impact factor: 6.968
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.